| 1 |
Cornwell AC, Feigin ME. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype. Trends Pharmacol Sci 2020;41:1006-22. [PMID: 33198923 DOI: 10.1016/j.tips.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Han L, Lin X, Yan Q, Gu C, Li M, Pan L, Meng Y, Zhao X, Liu S, Li A. PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene 2022. [PMID: 35140333 DOI: 10.1038/s41388-022-02197-x] [Reference Citation Analysis]
|
| 3 |
Chou SE, Lee KL, Wei PK, Cheng JY. Screening anti-metastasis drugs by cell adhesion-induced color change in a biochip. Lab Chip 2021;21:2955-70. [PMID: 34132296 DOI: 10.1039/d1lc00039j] [Reference Citation Analysis]
|
| 4 |
Qiu W, Wang Z, Chen R, Shi H, Ma Y, Zhou H, Li M, Li W, Chen H, Zhou H. Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p /Notch1 axis. Cancer Manag Res 2020;12:11121-31. [PMID: 33173345 DOI: 10.2147/CMAR.S269991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Zhang Y, Li L, Liu R, Zeng C. DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication. Biomed Res Int 2020;2020:9689312. [PMID: 32908930 DOI: 10.1155/2020/9689312] [Reference Citation Analysis]
|
| 6 |
Pham L, Kennedy L, Baiocchi L, Meadows V, Ekser B, Kundu D, Zhou T, Sato K, Glaser S, Ceci L, Alpini G, Francis H. Mast cells in liver disease progression: An update on current studies and implications. Hepatology 2022;75:213-8. [PMID: 34435373 DOI: 10.1002/hep.32121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Ning J, Ye Y, Bu D, Zhao G, Song T, Liu P, Yu W, Wang H, Li H, Ren X, Ying G, Zhao Y, Yu J. Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther 2021;29:2067-87. [PMID: 33601054 DOI: 10.1016/j.ymthe.2021.02.016] [Reference Citation Analysis]
|
| 8 |
Li H, Li Y, Tian D, Zhang J, Duan S. miR-940 is a new biomarker with tumor diagnostic and prognostic value. Mol Ther Nucleic Acids 2021;25:53-66. [PMID: 34168918 DOI: 10.1016/j.omtn.2021.05.003] [Reference Citation Analysis]
|
| 9 |
Zhu Q, Zhuang XX, Chen JY, Yuan NN, Chen Y, Cai CZ, Tan JQ, Su HX, Lu JH. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. Phytomedicine 2021;87:153578. [PMID: 34038839 DOI: 10.1016/j.phymed.2021.153578] [Reference Citation Analysis]
|
| 10 |
Peng J, Duan Z, Guo Y, Li X, Luo X, Han X, Luo J. Identification of candidate biomarkers of liver hydatid disease via microarray profiling, bioinformatics analysis, and machine learning. J Int Med Res 2021;49:300060521993980. [PMID: 33787392 DOI: 10.1177/0300060521993980] [Reference Citation Analysis]
|
| 11 |
Sharma A, Upadhyay V, Sarkar M, Mishra M, Thacker G, Trivedi AK. Proteomic analysis of TGFβ-induced A549 secretome identifies putative regulators of epithelial-mesenchymal transition. Biotechnol Appl Biochem 2021. [PMID: 33559923 DOI: 10.1002/bab.2121] [Reference Citation Analysis]
|
| 12 |
Nguyen PL, Cho J. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. Biomolecules 2021;11:1232. [PMID: 34439898 DOI: 10.3390/biom11081232] [Reference Citation Analysis]
|
| 13 |
Czerwiński M, Bednarska-Czerwińska A, Zmarzły N, Boroń D, Oplawski M, Grabarek BO. Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer. J Clin Med 2021;10:4872. [PMID: 34768392 DOI: 10.3390/jcm10214872] [Reference Citation Analysis]
|
| 14 |
Sarasola MP, Táquez Delgado MA, Nicoud MB, Medina VA. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 2021;9:e00778. [PMID: 34609067 DOI: 10.1002/prp2.778] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, Lin SH, Kuo PI, Chen WS, Lin YC, Chen JH, Liang YC, Chang CC. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection. J Clin Oncol 2022;:JCO2101802. [PMID: 35044851 DOI: 10.1200/JCO.21.01802] [Reference Citation Analysis]
|
| 16 |
Zhang C, Yu Y, Ma L, Fu P. Histamine H3 Receptor Promotes Cell Survival via Regulating PKA/CREB/CDKN1A Signal Pathway in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:3765-76. [PMID: 32440145 DOI: 10.2147/OTT.S250655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O'Byrne K, Rezaei N, Kulasinghe A. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev 2021;41:1474-98. [PMID: 33277742 DOI: 10.1002/med.21765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Liang S, Zhang X, Li J. Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma. Bioengineered 2022;13:7367-79. [PMID: 35297315 DOI: 10.1080/21655979.2022.2040827] [Reference Citation Analysis]
|
